Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke
Status:
Completed
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Along with the current clinical trial, the efficacy and safety of 180 mg loading dose of
ticagrelor administered within 24 hours of first-ever large-vessel ischemic stroke compared
to 300 mg clopidogrel were assessed through NIHSS, mRS, and possible adverse effects.